Cargando…
Clinical Implications and Translation of an Off-Target Pharmacology Profiling Hit: Adenosine Uptake Inhibition In Vitro
Off-target activities of drug candidates observed during in vitro pharmacological profiling frequently do not translate to adverse events (AEs) in human. This could be because off-target activities do not have functional consequences, are not observed at exposures achieved during clinical testing, o...
Autores principales: | Amouzadeh, Hamid R., Dimery, Isaiah, Werner, Jonathan, Ngarmchamnanrith, Gataree, Engwall, Michael J, Vargas, Hugo M., Arrindell, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657233/ https://www.ncbi.nlm.nih.gov/pubmed/31330495 http://dx.doi.org/10.1016/j.tranon.2019.05.018 |
Ejemplares similares
-
Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in vitro
por: Yamada, Reiko, et al.
Publicado: (2013) -
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
por: Stein, Anthony, et al.
Publicado: (2018) -
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors
por: Tran, Ben, et al.
Publicado: (2018) -
Turning up the adenosine turns off the spleen
por: Walkden, Michelle, et al.
Publicado: (2015) -
Pharmacology of Adenosine Receptors: Recent Advancements
por: Vincenzi, Fabrizio, et al.
Publicado: (2023)